Plain-English translation of NCT06605443 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing two non-invasive devices — a skin patch and a breath analyzer — to see if they can detect whether melanoma has spread to other parts of your body. These devices work by measuring certain chemicals your body naturally produces. The study will compare how well these new devices work compared to standard imaging scans (like PET or MRI) that doctors currently use.
Current methods for detecting whether melanoma has spread require invasive procedures and imaging scans that can be expensive and time-consuming. This study hopes to find a simpler, faster way to detect spread of melanoma using devices that are easier and less invasive for patients.
You likely qualify if…
You likely don't qualify if…
You will visit the study center where researchers will apply a skin patch to your skin and ask you to breathe into an analyzer device. These are simple, painless tests. At the same time, your doctors will use standard imaging tests (PET, MRI, etc.) and may take a blood sample to measure certain cancer markers. The study will last up to 24 months total, though your involvement may be shorter depending on your specific situation.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Spain
Fundacion Clinic per a la Recerca Biomédica
Collaborators
Hospital Clinic of Barcelona
Enrollment target
~100 participants
Started
January 2025
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Susana Puig Sardà, PhD, MD
Fundacion Clinic per a la Recerca Biomédica
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.